Gain Therapeutics Price Chart
Gain Therapeutics Volume Chart
Gain Therapeutics Market Segments
Regular Trading Hours
+0.04(+1.54%)
| Open | $2.60 |
|---|---|
| Close | $2.64 |
| Low | $2.53 |
| Low Change | -0.07 (-2.69%) |
| High | $2.70 |
| High Change | +0.10 (+3.85%) |
| Range | $0.17 |
| Volume | 513.693K |
| Dollar Volume | $1.36M |
Premarket
-0.09(-3.36%)
| Open | $2.68 |
|---|---|
| Close | $2.59 |
| Low | $2.53 |
| Low Change | -0.15 (-5.60%) |
| High | $2.69 |
| High Change | +0.01 (+0.37%) |
| Range | $0.16 |
| Volume | 4.139K |
| Dollar Volume | $10.72K |
After Hours Yesterday
-0.01(-0.40%)
| Open | $2.58 |
|---|---|
| Close | $2.57 |
| Low | $2.48 |
| Low Change | -0.11 (-4.07%) |
| High | $2.58 |
| High Change | +0.00 (+0.00%) |
| Range | $0.11 |
| Volume | 7.196K |
| Dollar Volume | $18.49K |
Regular Trading Hours Yesterday
+0.02(+0.80%)
| Open | $2.50 |
|---|---|
| Close | $2.52 |
| Low | $2.44 |
| Low Change | -0.06 (-2.40%) |
| High | $2.63 |
| High Change | +0.13 (+5.20%) |
| Range | $0.19 |
| Volume | 541.022K |
| Dollar Volume | $1.36M |
Premarket Yesterday
-0.04(-1.40%)
| Open | $2.58 |
|---|---|
| Close | $2.54 |
| Low | $2.54 |
| Low Change | -0.04 (-1.60%) |
| High | $2.58 |
| High Change | +0.00 (+0.00%) |
| Range | $0.04 |
| Volume | 2.675K |
| Dollar Volume | $6.81K |
Gain Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.68 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.71 |
| 20 Day Moving Average (SMA20) | $2.49 |
| 50 Day Moving Average (SMA50) | $2.23 |
| 100 Day Moving Average (SMA100) | $2.55 |
| 200 Day Moving Average (SMA200) | $2.15 |
Gain Therapeutics Statistics
| Average Volume (30 Days) | 718.29K |
|---|---|
| P/E Ratio (Current) | -4.86 |
| EPS (Current) | -$0.50 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$17.30M |
| Cash Ratio | 2.11 |
| Current Ratio | 2.52 |
| Quick Ratio | 2.52 |
| Debt to Equity | 0.07 |
| Enterprise Value | $85.08M |
| EV to EBITDA | -4.86 |
| EV to Sales | — |
| Price to Book | 15.82 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.77% |
| Return on Equity | -3.28% |
Gain Therapeutics Stock Splits
There have been no stock splits for Gain Therapeutics (GANX).
Gain Therapeutics Dividends
There have been no dividends for Gain Therapeutics (GANX).